149 related articles for article (PubMed ID: 19200017)
1. LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer.
Vana K; Zuber C; Pflanz H; Kolodziejczak D; Zemora G; Bergmann AK; Weiss S
Infect Disord Drug Targets; 2009 Feb; 9(1):69-80. PubMed ID: 19200017
[TBL] [Abstract][Full Text] [Related]
2. Interactions between PrP(c) and other ligands with the 37-kDa/67-kDa laminin receptor.
Mbazima V; Da Costa Dias B; Omar A; Jovanovic K; Weiss SF
Front Biosci (Landmark Ed); 2010 Jun; 15(3):1150-63. PubMed ID: 20515747
[TBL] [Abstract][Full Text] [Related]
3. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor.
Zuber C; Knackmuss S; Zemora G; Reusch U; Vlasova E; Diehl D; Mick V; Hoffmann K; Nikles D; Fröhlich T; Arnold GJ; Brenig B; Wolf E; Lahm H; Little M; Weiss S
J Mol Biol; 2008 May; 378(3):530-9. PubMed ID: 18387633
[TBL] [Abstract][Full Text] [Related]
4. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy.
Zuber C; Mitteregger G; Schuhmann N; Rey C; Knackmuss S; Rupprecht W; Reusch U; Pace C; Little M; Kretzschmar HA; Hallek M; Büning H; Weiss S
J Gen Virol; 2008 Aug; 89(Pt 8):2055-2061. PubMed ID: 18632978
[TBL] [Abstract][Full Text] [Related]
5. Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.
Omar A; Jovanovic K; Da Costa Dias B; Gonsalves D; Moodley K; Caveney R; Mbazima V; Weiss SF
Expert Opin Ther Pat; 2011 Jan; 21(1):35-53. PubMed ID: 21110766
[TBL] [Abstract][Full Text] [Related]
6. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes.
Gauczynski S; Nikles D; El-Gogo S; Papy-Garcia D; Rey C; Alban S; Barritault D; Lasmezas CI; Weiss S
J Infect Dis; 2006 Sep; 194(5):702-9. PubMed ID: 16897671
[TBL] [Abstract][Full Text] [Related]
7. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein.
Gauczynski S; Peyrin JM; Haïk S; Leucht C; Hundt C; Rieger R; Krasemann S; Deslys JP; Dormont D; Lasmézas CI; Weiss S
EMBO J; 2001 Nov; 20(21):5863-75. PubMed ID: 11689427
[TBL] [Abstract][Full Text] [Related]
8. Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.
Jovanovic K; Gonsalves D; Da Costa Dias B; Moodley K; Reusch U; Knackmuss S; Penny C; Weinberg MS; Little M; Weiss SF
Sci Rep; 2013; 3():2699. PubMed ID: 24048412
[TBL] [Abstract][Full Text] [Related]
9. Prion interaction with the 37-kDa/67-kDa laminin receptor on enterocytes as a cellular model for intestinal uptake of prions.
Kolodziejczak D; Da Costa Dias B; Zuber C; Jovanovic K; Omar A; Beck J; Vana K; Mbazima V; Richt J; Brenig B; Weiss SF
J Mol Biol; 2010 Sep; 402(2):293-300. PubMed ID: 20603132
[TBL] [Abstract][Full Text] [Related]
10. Expression and distribution of laminin receptor precursor/laminin receptor in rabbit tissues.
Wang H; Yang L; Kouadir M; Tan R; Wu W; Zou H; Wang J; Khan SH; Li D; Zhou X; Yin X; Wang Y; Zhao D
J Mol Neurosci; 2013 Oct; 51(2):591-601. PubMed ID: 23715696
[TBL] [Abstract][Full Text] [Related]
11. Patented therapeutic approaches targeting LRP/LR for cancer treatment.
Vania L; Morris G; Otgaar TC; Bignoux MJ; Bernert M; Burns J; Gabathuse A; Singh E; Ferreira E; Weiss SFT
Expert Opin Ther Pat; 2019 Dec; 29(12):987-1009. PubMed ID: 31722579
[No Abstract] [Full Text] [Related]
12. Diverse patterns of expression of the 67-kD laminin receptor in human small intestinal mucosa: potential binding sites for prion proteins?
Shmakov AN; Bode J; Kilshaw PJ; Ghosh S
J Pathol; 2000 Jul; 191(3):318-22. PubMed ID: 10878555
[TBL] [Abstract][Full Text] [Related]
13. Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer's disease.
Jovanovic K; Chetty CJ; Khumalo T; Da Costa Dias B; Ferreira E; Malindisa ST; Caveney R; Letsolo BT; Weiss SF
Expert Opin Ther Pat; 2015 May; 25(5):567-82. PubMed ID: 25747044
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches targeting the prion receptor LRP/LR.
Zuber C; Ludewigs H; Weiss S
Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
[TBL] [Abstract][Full Text] [Related]
15. Anti-LRP/LR-specific antibody IgG1-iS18 impedes adhesion and invasion of pancreatic cancer and neuroblastoma cells.
Rebelo TM; Chetty CJ; Ferreira E; Weiss SF
BMC Cancer; 2016 Nov; 16(1):917. PubMed ID: 27884119
[TBL] [Abstract][Full Text] [Related]
16. Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neurons.
Baloui H; von Boxberg Y; Vinh J; Weiss S; Rossier J; Nothias F; Stettler O
Eur J Neurosci; 2004 Nov; 20(10):2605-16. PubMed ID: 15548204
[TBL] [Abstract][Full Text] [Related]
17. Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.
Vania L; Morris G; Ferreira E; Weiss SFT
BMC Cancer; 2021 Apr; 21(1):392. PubMed ID: 33836696
[TBL] [Abstract][Full Text] [Related]
18. LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.
Pinnock EC; Jovanovic K; Pinto MG; Ferreira E; Dias Bda C; Penny C; Knackmuss S; Reusch U; Little M; Schatzl HM; Weiss SF
J Alzheimers Dis; 2016; 49(3):645-57. PubMed ID: 26484914
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of full-length coding sequence (CDS) of the ovine 37/67-kDa laminin receptor (RPSA).
Qiao J; Su X; Wang Y; Yang J; Kouadir M; Zhou X; Yin X; Zhao D
Mol Biol Rep; 2009 Nov; 36(8):2131-7. PubMed ID: 19105045
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells.
Khumalo T; Ferreira E; Jovanovic K; Veale RB; Weiss SF
PLoS One; 2015; 10(10):e0139584. PubMed ID: 26427016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
